New Zealand banks and post office hit by blackouts in apparent cyberattack, IT News, ET CIO


By Paulina Duran

SYDNEY: The websites of a number of financial institutions in New Zealand and its national postal service were briefly shut down on Wednesday, with officials saying they were battling a cyber attack.

The country’s Computer Emergency Response Team (CERT) said it was aware of a DDoS (Distributed Denial of Service) attack targeting a number of organizations in the country.

It was “monitoring the situation and working with affected parties to the extent possible,” CERT said on its website.

Some of the websites affected by the attack, according to local media reports, included the New Zealand site of the Australian and New Zealand banking group and NZ Post.

In a Facebook post, ANZ told its customers it knew some of them were unable to access online banking. “Our technical team is working hard to resolve this issue, we apologize for any inconvenience this may cause,” the post said.

ANZ representatives did not immediately return requests for comment.

NZ Post said the “intermittent disruption” on its website was due to a problem with one of its third-party vendors.

Several clients have taken to social media to report outages at Kiwibank, a small lender partially owned by the NZ Post. Kiwibank apologized to customers in a Twitter post and said it was working to fix “intermittent access” to services from its app, online banking, phone banking and phone banking. his website.

In DDoS attacks, the servers of leading institutions are crowded out by inbound traffic from superfluous requests that attempt to overload the system and drown out legitimate requests.

In January, a cyberattack resulted in a serious data breach at the New Zealand central bank, which followed several attacks on the New Zealand stock exchange operator a year ago.

A group of hackers also targeted hospitals in May.

Source link

About Warren Dockery

Check Also

Chinese Zero Covid Strategy vs Indian Democratic Covid Strategy

Data from the Phase 3 trial of Covaxin published in Lancet and tweeted by NIH …

Leave a Reply

Your email address will not be published. Required fields are marked *